Publication Details
Publication: Health Industry News Flash (健康産業速報), No. 3050
Publication Date: July 31, 2026
Original Language: Japanese
English Translation of the Published Article
The following English text is a faithful translation of the information presented in the original Japanese media article. Statements concerning study outcomes, functions, or market response are presented as reported by the publication and should be read in that context.
Toei Shinyaku Reports New Agaricus KA21 Data
Toei Shinyaku reported new research data on outdoor-cultivated Agaricus KA21 at the 26th Annual Meeting of the Japanese Society of Anti-Aging Medicine, where the presentation was selected as an excellent presentation.
β-Glucan Research with Tokyo University of Pharmacy and Life Sciences
In collaborative research with Tokyo University of Pharmacy and Life Sciences, the researchers used patented β-glucan quantification technology developed jointly by the parties. The article reports that β-glucans derived from orally administered outdoor-cultivated Agaricus KA21 were detected in the body and accumulated in the liver. The study also examined biological responses related to the β-glucan findings.
Research on Middle-Aged and Older Men
The article additionally reports collaborative research with Shigakkan University, the National Center for Geriatrics and Gerontology, and other research institutions involving human clinical data in middle-aged and older men. A randomized, double-blind, crossover study was conducted in men aged 40 years and older, and the publication reported favorable findings in several men’s health-related measures.
日本語記事概要 / Japanese Summary
健康産業速報2026年7月31日号で、露地栽培アガリクスKA21に関する新たな研究データが紹介されました。東京薬科大学との共同研究では、β-グルカン定量に関する特許技術を活用し、経口摂取したKA21由来β-グルカンの体内動態を検討しました。この研究は第26回日本抗加齢医学会総会で発表され、優秀演題に採択されました。また、至学館大学、国立長寿医療研究センターなどとの共同研究による中高齢男性を対象としたヒト臨床研究についても紹介されています。
Original Japanese Article (PDF)
The original Japanese article is available in PDF format. Please refer to the original publication for the source article.